REPRODUCTIVE HORMONE TEST REQUESTING Jeffrey Barron Consultant Chemical Pathologist Epsom & St Helier University Hospitals 03.07.2007 EFFECTIVE REPRODUCTIVE.

Slides:



Advertisements
Similar presentations
MANAGEMENT OF INFERTILITY CURRENT GUIDELINES
Advertisements

 Ultrasound pelvis  Full blood count  Pap smear  Coagulation profile  Liver function tests  Serum Iron  Serum ferritin  Endometrial biopsy 
Amenorrhea Dr.F Mehrabian MD
EVALUATION AND MANAGEMENT OF AMENORRHEA Assistant Professor at JUH
CASE PRESENTATION (4)(6)(7)
Abnormal uterine bleeding
DYSFUNCTIONAL UTERINE BLEEDING
Fawaz Edris MD, RDMS, FRCSC, FACOG, AAACS. INTRODUCTION 1/3 of outpatient visits Most after menarche or perimenopausal Multiple causes, but mostly: Pregnancy.
The Gynaecology Clinic Michaelmas term year 2. This session will: Cover definitions of amenorrhoea and oligomenorrhoea Explain the genetic, anatomical.
Commenting on amenorrhoea, or how to get sued. Five cases will be presented 25 of the audience will be asked to assess interpretative ideas or whole comments.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
IN THE NAME OF GOD Elham Faghihimani endocrinologist.
Valerie Robinson, DO. Polycystic Ovarian Syndrome (PCOS) is a disorder that causes menstrual and ovulation irregularities, androgen excess, and infertility.
Emily Bartlett Katrina Bush
PCOS Polycystic Ovary Syndrome
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Osman Donia Amenorrhea Prof. Obstet. Gynaecol.,. Osman Donia.
DR MANAL IDRIS menorrhagia. Introduction Menorrhagia is one of the commenest gynaecological complaints seen in practice and accounts for approximately.
General Medicine Conference “Hirsutism” General Medicine Conference “Hirsutism” Selim Krim, MD Assistant professor Texas Tech University Health Sciences.
Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA.
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
HIRSUTISM. Definition  Hirsutism Excessive growth of hair in abnormal position on the body  Virilism Masculinization of female i.e. deepening of voice,
Christopher R. Graber, MD Salina Women’s Clinic 10 Dec 2010.
Ku č era, E..  Normal menstrual cycle  21 – 36 days interval between bleeding  duration of bleeding is 2 – 8 days  average is 5 days  blood loss.
AMENORRHEA Paul Beck, MD, FACOG, FACS. Incidence of Primary Amenorrhea Less than.1% Puberty Breast: / yrs. Pubic Hair:11.0 +/ yrs. Menarche12.9.
Menstruation Is the endpoint of a cascade of events which begins in the hypothalamus and ends at the uterus.
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
Conférence Etudiant Jeudi le 3 septembre 2015 Jonathan Gravel Hassan Khanafer.
Amenorrhea (and Dysfunctional Uterine Bleeding)
Amenorrhea DI WEN M.D., Ph.D., DI WEN M.D., Ph.D., Professor & Chairman Professor & Chairman Department Of Obstetrics & Gynecology Department Of Obstetrics.
Polycystic Ovarian Disorder Max Brinsmead MB BS PhD August 2014.
Amenorrhea Dr Nadia algantary Associated proffessor Faculty of medicine.
Investigation of Infertility
Amenorrhea Dr Jack Biko.
Secondary Sex Traits. Hormones – Proteins made in the brain and sex organs Hormones – Proteins made in the brain and sex organs.
Amenorrhoea – A Clinician’s Approach Max Brinsmead MB BS PhD May 2015.
Amenorrhea & Anovulation Andrea Chymiy, MD Swedish Family Medicine.
ANOVULATION CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA.
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
Prof Lindeque Abnormal excessive uterine bleeding.
Investigating infertile couple
Laboratory evaluation of amenorrhoea
Please Be Sure You Have An Audience-Response Device (Clicker)
PROFESSOR ZEINAB ABOTALIB Consultant Obstetrics & Gynaecology and infertility.
Physiopathology and diagnosis of PCOS Ertan SARIDOĞAN Consultant in Reproductive Medicine and Minimal Access Surgery University College London Hospitals.
Emad R. Sagr, MBBS, FRCSC, FACOG Consultant Obstetrics & Gynecology and Gynecology Oncology Security Forces Hospital.
Investigations of infertility
THE REPRODUCTIV E SYSTEM. Functional anatomy, physiology and investigations In the male, the testis subserves two principal functions: 1.synthesis of.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Case history, physical examination, investigations The Question behind the Question ???? Clinical methodology;
Infertility Dr Ismat Batool. DEFINITION Infertility is defined as the inability to conceive despite regular unprotected intercourse over a specific period.
Infertility. Objectives of this lecture: 1.To define infertility. 2.To know the prevalence and types of infertility. 3.To know the requirement of normal.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
DR.GARIMA TYAGI Senior Consultant Obstetrician,Gynaecologist Infertility consultant & Laparoscopic Surgeon SHREE NARAYAN HOSPITAL, INDIRAPURAM,GHAZIABAD.
Patient no 2 A 29 years old male is being investigated for infertility along with his female partner. He has no history of loss of libido, impotence or.
King Khalid University Hospital Department of Obstetrics & Gynecology
Primary AmenorrhoeaPrepared by Professor Dr.Lilyan Sersam
Endometrial hyperplasia
Diagnosis and clinical manifestation
AMENORRHEA APPROACH TO AMENORRHEA Primary Amenorrhea?
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
Fertility Assessment & Treatment
PRIMARY AMENORRHOEA.
Amenorrhea Dr Ferdous Mehrabian Professor of Isfahan university
Dr Emma Park GP trainer Lead GP CASES project Primary Care Sheffield
CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA
Presentation transcript:

REPRODUCTIVE HORMONE TEST REQUESTING Jeffrey Barron Consultant Chemical Pathologist Epsom & St Helier University Hospitals EFFECTIVE REPRODUCTIVE HORMONE TEST REQUESTING EASY GUIDE Jeffrey Barron Chemical Pathologist Labtests Goodfellows

Outline of Talk - Female Laboratory role Hypothalamic-Pituitary-Ovarian axis Amenorrhoea: Secondary –Oligo- & Amenorrhoea: FSH interpretation Prolactin Raised: Galactorrhoea Testosterone raised: –Polycystic Ovarian Syndrome –Hirsutism, Virilisation Menopause Infertility - Subfertility Recommendations for requesting

Laboratory Role: As You May See It Specimen InputProcess Lab Output Results Productivity Request

Laboratory Role: How We Add Value Input Clinical & Scientific Expertise ProcessOutput Reason Request Tests DataKnowledge, Expert Algorithms Clinical Advice Lab Productivity Value

Hypothalamic-Pituitary-Ovarian axis uterus menses Testosterone-theca cells/stroma

Amenorrhoea ?

Amenorrhoea Physiological –Prior to puberty –Pregnancy –Lactation –Menopause Secondary –Gynaecological disorder –Systemic disease

FSH & LH levels vary

FSH levels vary

Amenorrhoea ?

Consider: - Pregnancy - Lactation - Exercise - Weight loss / Coeliac disease - Severe illness If none of above request: - FSH, LH - Prolactin - Testosterone - Oestradiol to interpret FSH or guide Rx - Consider TSH Oligo- & Amenorrhoea: Secondary Previously regular-None for 6 months

Amenorrhoea ?

FSH high:Ovarian failure – early karyotype FSH low to low normal: - Pregnancy - Lactation - Exercise - Weight loss - Severe illness - Stress - Contraceptive drugs - Hypothalamic/Pituitary disease or masses Uterine: Asherman’s syndrome Oligo- & Amenorrhoea: Secondary FSH

Pregnancy Lactation Stress Drugs: neuroleptics, SSRI, tricyclics, metoclopramide, domperidone, other 1 o hypothyroidism Macroprolactin - prolactin~IgG Pituitary adenoma Oligo- & Amenorrhoea: Secondary Prolactin raised

Galactorrhoea - 1 Juno holding her breast for Hercules in The birth of the Milky Way, Peter Paul Rubens 1637

Sample Collection: day 2 - 5, after midday: menses + diurnal rhythms Galactorrhoea &/or oligo-amenorrhoea + raised prolactin + correct sample + no medication + not macroprolactin + not pregnant, lactation, hypothyroidism = possible prolactinoma Galactorrhoea Prolactin raised

Prolactin mIU/L - Suggest review medication - Examine for galactorrhoea - Repeat on day 2 – 5, after midday Repeat or > 800 mIU/L - Lab phone to review medication, lactation, clinical - Exclude macroprolactin: prolactin~IgG - Recommend: Repeat on day 2 – 5 Endocrine referral Raised Prolactin No Galactorrhoea or Amenorrhoea

Hirsutism

PCOS - most common cause Hirsutism:mild severe Virilisation Oligo- & Amenorrhoea: Secondary Testosterone raised

Ferriman-Gallwey hirsutism scoring system

Testosterone Total vs Hirsutism Score Mayo Clinic specific testosterone assay RS Legro et al, Total Testosterone Assays in Women with Polycystic Ovary Syndrome: Precision and Correlation with Hirsutism, J Clin Endocrinol Metab. 2010; 95: 5305 – 5313 Hirsutism Score 2.6 nmol/L 4.5 TestosteroneTestosterone

Ideal diagnostic test Normal Disease No false positives or negatives Probability

No disease Normal Reference interval 95% PCOS or Hirsutism No. of individuals Concentration Testosterone in PCOS False positives False negatives

Hirsutism

Polycystic Ovarian Syndrome - 1 Common, 5 – 10% young women 21% NZ women, reproductive age –ultrasound shows PCO Presentation: ~ half patients –Anovulatory infertility –Oligomenorrhoea –Hirsutism, acne, male type baldness Familial Linked: type II diabetes

Hypothalamic-Pituitary-Ovarian axis uterus menses Testosterone-theca cells/stroma

Hirsutism & Acne

Polycystic Ovarian Syndrome – 2 Diagnosis Request: Testosterone, day –Increased ~ 70% patients PCOS –Fulfills 1 of 3 criteria for diagnosis Other criteria: –Oligo- &/or anovulation –Ultrasound PCO FSH & LH NOT reliable criteria Clinically Testosterone not necessary Martin KA et al DIAGNOSIS AND EVALUATION OF WOMEN WITH PREMENOPAUSAL HIRSUTISM J Clin Endocrinol Metab: 93 (4), , 2008 Fritz M & Speroff L, Clinical Gynaecological Endocrinology & Infertility, 8 th Ed, 2011.

Testosterone Total vs Hirsutism Score Mayo Clinic specific testosterone assay RS Legro et al, Total Testosterone Assays in Women with Polycystic Ovary Syndrome: Precision and Correlation with Hirsutism, J Clin Endocrinol Metab. 2010; 95: 5305 – 5313 Hirsutism Score 2.6 nmol/L 4.5 TestosteroneTestosterone

Diagnosis of Hirsutism Isolated mild - no request for testosterone Moderate / severe, sudden onset, progressive –Especially associated with: menstrual irregularity, infertility, central obesity, acanthosis nigricans, rapid progression, clitoromegaly Testosterone: day Normal: no further tests Rapid progression or virilisation: –Consider androgen secreting tumour Martin, Evaluation and treatment of hirsutism in premenopausal women. J Clin Endocrinol Metab: 93 (4), , 2008

Hirsutism

Hirsutism, Amenorrhoea Hirsutism occurs most commonly with PCOS Initial test: –Testosterone total: day 2- 5, morning Testosterone free –adds no further diagnostic information –unnecessary test Martin KA et al DIAGNOSIS AND EVALUATION OF WOMEN WITH PREMENOPAUSAL HIRSUTISM J Clin Endocrinol Metab: 93 (4), , 2008

Hirsutism, Amenorrhoea High testosterone or progression If Testosterone total > 4.5 nmol/L –Lab request DHEAS, Testosterone free Or Rapid progression hirsutism, virilisation –Consider androgen secreting tumour –Request Testosterone free DHEAS Martin KA et al DIAGNOSIS AND EVALUATION OF WOMEN WITH PREMENOPAUSAL HIRSUTISM J Clin Endocrinol Metab: 93 (4), , 2008

Hirsutism, Virilisation, Amenorrhoea Adult onset CAH is not an issue Adult onset CAH, is NOT adrenal insufficiency, normal cortisol Consider if: early onset hirsutism or ethnic origin is: –Mediterranean, Slavic, Ashkenazi Jewish If presenting with hirsutism alone –Anti-androgen therapy equivalent to glucocorticoid therapy Diagnosis: day 2 – 5, morning 17 OH progesterone

Hirsutism, Virilisation, Amenorrhoea Androstenedione is not necessary Commonly elevated No diagnostic value over testosterone Used:Diagnosis or management CAH Androgen secreting tumours of adrenal or ovary

Ovarian Cycle Progesterone

Regular cycles: ovulation likely Monitor pituitary-ovarian axis to confirm ovulation: Request: Midluteal progesterone on day 21 if 28 day cycle If midluteal progesterone: > 25 nmol/L: - Consistent with ovulation - No further hormone tests required Irregular cycles – repeat progesterone weekly Require progesterone, 7 days pre onset menses Infertility or Subfertility - 1

If day 21 progesterone < 25 nmol/L Then repeat twice: - Midluteal progesterone - on day 21 if a 28 day cycle Infertility or Subfertility - 2

Infertility or Subfertility – 3 If Progesterone < 25 nmol/L after 3 cycles Request on day 2 - 5: –FSH, LH –Prolactin –Testosterone –Oestradiol –Consider TSH

Use of Serum Progesterone To determine –If ovulating –Specialist use if possible risk Miscarriage Ectopic pregnancy

Thought to be Post Menopausal. Now pregnant

FSH & LH levels vary

> 45 years, with typical symptoms: No tests Atypical - Request FSH, LH on day 2 – 5 Perimenopause FSH > LH - FSH > 30 mIU/L FSH fluctuates perimenopause 40 mIU/L - on 2 occasions 8 weeks apart = ovulatory failure Oestradiol normal until perimenopause Menopausal Symptoms + Oligo- or Poly-Menorrhoea

Result: FSH > LH, FSH >30, Age <45 Biochemically consistent with premature ovarian failure Result: FSH > LH, FSH 10 – 30, Age >45 Consider early stage of perimenopause Result:FSH > LH, FSH 10 – 30, Age <45 Consider early stage of premature ovarian failure Menopausal Symptoms + Oligo- or Poly-Menorrhoea

Peri-Menopause - 1 FSH fluctuates markedly History basis of diagnosis. Therapeutic trial HRT No place assays: oestradiol, progesterone Thyroid disease symptoms may mimic menopausal symptoms

Peri-Menopause – 2 Request FSH if Not on HRT, oestrogen pill Hysterectomy with ovarian conservation Menstrual bleeding FSH on day 2 – 5 –FSH > LH –Raised > 10 mIU/L –Indicates diminished ovarian response

Request: - FSH, LH - Prolactin - Testosterone - Oestradiol Oligo- or Poly-Menorrhoea NO Menopausal Symptoms

The Toilet of Venus 1650 Venus - Diego Velazquez

Recommendations for requesting - 1 Primary Amenorrhoea: –FSH, LH Secondary Oligo-, Poly-, A-menorrhoea : –FSH, LH, Prolactin, Testosterone total, Oestradiol Hirsutism, Polycystic Ovarian Syndrome: –Testosterone total on day Menopause atypical: –FSH, LH on day 2 - 5

Recommendations for requesting - 2 Galactorrhoea –Prolactin on day 2 - 5, after 12 midday Infertility: –Progesterone day 21

Dysfunctional Uterine Bleeding Menorrhagia Intermenstrual or post coital Abdominal and pelvic examination FBC: exclude anaemia HCG: Exclude pregnancy / trophoblast Consider TSH if symptoms or signs No other hormone investigations History: consider clotting disorder Dysmenorrhoea: Laboratory tests not necessary

Post Pill Amenorrhoea Weight Loss Hypopituitarism Low –LH, FSH –Oestradiol

Libido Loss Common Tests only if indicated by history & examination Weak correlation with testosterone, DHEAS, androstenedione, oestradiol, FSH, prolactin Rare causes consider: acromegaly, Cushing's syndrome, CAH, adrenal insufficiency

Hypothyroidism increases Prolactin

Amenorrhoea: Primary Failure to establish menstruation Absent by 13 years - Without secondary sexual development Absent by 16 years - With secondary sexual characteristics

Family history:Consider watchful waiting Request: FSH, LH - Raised: Karyotype: 45 XO Turner syn 46 XX Premature ovarian failure - Low: Constitutional delay Consider:anorexia exercise illness coeliac disease hypothalamic/pituitary - Intermediate: Anatomical - ultrasound Amenorrhoea: Primary Secondary sexual characteristics Absent 13y

Absent/abnormal then karyotype: - 46 XX Mullerian agenesis - 46 XY Androgen insensitivity Present + no outflow obstruction - As for 2 o amenorrhoea Amenorrhoea: Primary Secondary sexual characteristics Present by 16 years Ultrasound uterus